RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @CircHF: #MethodsPaper from @HenriksenDr et al published in #CircHF: Cardiac CARE will use high sensitive troponin I testing to guide ca…
RT @CircHF: #MethodsPaper from @HenriksenDr et al published in #CircHF: Cardiac CARE will use high sensitive troponin I testing to guide ca…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @kaufman_renato: #cardioonc trial https://t.co/wjbu7rn0hi
RT @kaufman_renato: #cardioonc trial https://t.co/wjbu7rn0hi
RT @kaufman_renato: #cardioonc trial https://t.co/wjbu7rn0hi
#cardioonc trial
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @CircHF: #MethodsPaper from @HenriksenDr et al published in #CircHF: Cardiac CARE will use high sensitive troponin I testing to guide ca…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @CircHF: #MethodsPaper from @HenriksenDr et al published in #CircHF: Cardiac CARE will use high sensitive troponin I testing to guide ca…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @CircHF: #MethodsPaper from @HenriksenDr et al published in #CircHF: Cardiac CARE will use high sensitive troponin I testing to guide ca…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
RT @HenriksenDr: Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninia…
Very pleased to report Cardiac CARE results at #ESCCongress (26-29 Aug) late breaking science @NIHRresearch @TheBHF @ninianlang @HighSTEACS @ICOSociety
RT @CircHF: #MethodsPaper from @HenriksenDr et al published in #CircHF: Cardiac CARE will use high sensitive troponin I testing to guide ca…
#MethodsPaper from @HenriksenDr et al published in #CircHF: Cardiac CARE will use high sensitive troponin I testing to guide cardioprotection for patients at risk of anthracycline cardiotoxicity https://t.co/VW3iEuos2V #AHAJournals @EdinUniCVS @EdinUniECT
Rationale and Design of the #Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of #Anthracycline Cardiotoxicity https://t.co/3lGWeDMHAY #Cancer @VelindreCC
RT @troponinpapers: Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Pr…
RT @troponinpapers: Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Pr…
Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity #lymphoma #lymsm https://t.co/8zyC8O4YuK
Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity https://t.co/nfNQtIppp1
Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity https://t.co/pDXY2Uwqe2
New article: Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity https://t.co/NXRW2SbZgm #breastcancer #oncology https://t.co/UhbNH3PcYK
Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity #lymphoma #lymsm https://t.co/DKWLnfiPEp
Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity https://t.co/KjxWy6U0JY https://t.co/kYZzuZuuD2